Xeroform Gauze Dressing For Surgical Incision Odor Control
Understanding Odor Control Challenges in Surgical Incision Care
Postoperative wound management presents a persistent clinical challenge: controlling bacterial colonization, odor, and infection risks while preserving fragile healing tissue. Among the recurring pain points clinicians and patients face during recovery are secondary trauma from dressing changes, bacterial odor from exuding incision sites, and the discomfort caused by gauze that adheres to newly formed granulation tissue. Addressing these interconnected issues requires a dressing material engineered with both antimicrobial function and atraumatic design—an area where Roosin Medical has built specialized expertise through its Xeroform Gauze Dressing.
What Is Xeroform Gauze Dressing
Xeroform Gauze Dressing, manufactured by Roosin Medical Co., Ltd., is a fine-mesh cotton gauze impregnated with petrolatum and 3% Bismuth Tribromophenate. This formulation is designed to provide a non-adherent, antimicrobial, and deodorizing moist healing environment suitable for both human acute and surgical wound care, as well as veterinary trauma management across canine, feline, and equine applications.
The dressing’s positioning directly addresses a well-documented clinical reality: surgical incisions, superficial burns, donor sites, and open wounds are vulnerable to bacterial colonization that produces unpleasant odor and elevates infection risk. At the same time, conventional gauze often adheres to healing tissue, causing secondary trauma, tissue tearing, and sharp pain during dressing changes. Xeroform Gauze Dressing is formulated to manage both concerns simultaneously.

How the Formulation Supports Odor Control
The 3% Bismuth Tribromophenate component functions as an antiseptic and bacteriostatic agent. It works by stopping bacterial reproduction at the wound site, which in turn serves as a deodorizing mechanism to control the discharge odor commonly associated with surgical incisions and other open wounds. This mechanism is particularly relevant for postoperative care, where bacterial buildup within incision sites can generate noticeable odor if left unmanaged.
Complementing the antiseptic action, the petrolatum and paraffin coating creates a non-adherent, lubricating barrier. This layer protects delicate granulation tissue from disruption and facilitates painless, trauma-free removal—an important consideration for patients undergoing repeated dressing changes during the postoperative recovery window.
Structural Design for Clinical Versatility
Xeroform Gauze Dressing is built on a fine-mesh woven cotton gauze matrix that is soft, conformable, and trimmable. This structural quality allows the dressing to cling smoothly to irregular wound contours without fraying into the wound bed—a practical advantage when managing surgical incision sites that may vary in shape and depth.
For deeper or more complex postoperative needs, the product is also available in a packing strip format: a slender, conformable ribbon that enables non-adherent packing of narrow bite punctures, abscess drain tracts, and surgical cavity sites. This dual-format availability (sheet and packing strip) gives clinicians flexibility depending on the nature of the surgical wound being managed.
Supporting Evidence From Clinical Use
According to information provided by Roosin Medical, Xeroform Gauze Dressing has been used in acute and postoperative wound management, including applications on skin graft recipient and donor sites, minor partial-thickness burns, and surgical incisions. In these contexts, the dressing has been applied to support clean, odor-free recovery without disrupting newly formed epidermal layers during dressing changes.
In veterinary settings, the same formulation has been applied to canine spay and neuter suture lines, feline bite lacerations, and equine distal limb wounds. The reported outcome in these cases is the prevention of bandage adhesion to surrounding fur and granulation tissue, which reduces animal struggle and pain during dressing changes—illustrating the dressing’s broader applicability across both human and veterinary surgical contexts.
Manufacturing Standards Behind the Product
Clinical confidence in a wound care product depends heavily on the manufacturing environment and regulatory compliance behind it. Xeroform Gauze Dressing is manufactured as a sterile, latex-free, single-use device produced under medical-grade standards, including ISO 13485 and CE/FDA compliance, making it suitable for sterile surgical and veterinary clinical protocols.
This regulatory foundation reflects the broader manufacturing infrastructure at Roosin Medical, which operates a 10,000 m² facility equipped with ISO Class 7/8 cleanrooms and automated production lines. The company maintains dual R&D centers in Shanghai and Taizhou, combining global biomedical research talent with three decades of accumulated technical expertise in functional dressing lines and biomaterials. This infrastructure supports consistent product quality across the sizes available for Xeroform Gauze Dressing, including 5×5 cm, 10×10 cm, 2.5×20 cm, and 12.5×22.5 cm formats, as well as customizable OEM/ODM specifications for institutional buyers.
Why Surgical Teams Consider This Dressing Format
For hospital procurement teams and clinicians managing postoperative incision care, the combination of antimicrobial odor control and atraumatic removal addresses two frequently cited concerns in dressing selection: infection risk and patient comfort during care. Rather than treating odor control and pain-free removal as separate problems requiring separate products, Xeroform Gauze Dressing integrates both functions into a single formulation.
This is particularly relevant in settings such as dermatology and plastic surgery (for skin graft management), emergency wound care for lacerations and abrasions, and post-surgical recovery wards where incision sites require regular monitoring and dressing changes. The product’s adaptation across superficial burn care, post-surgical care, and low-exudate chronic ulcer management further demonstrates the versatility of the formulation beyond strictly surgical applications.
A Broader Perspective on Wound Care Strategy
Roosin Medical’s approach to Xeroform Gauze Dressing reflects a broader corporate positioning around addressing documented pain points in wound care: secondary trauma during dressing changes, infection risk in exuding wounds, and the need for clinical-grade efficacy without added patient discomfort. The company, founded in 1996, exports to 87 countries, with the United States and Europe representing its primary market focus areas, and holds regulatory clearances including EU MDR certification (TÜV Rheinland) and US FDA 510(k) clearance for its collagen dressing line, alongside ISO 13485:2016 and MDSAP compliance.
For procurement decision-makers evaluating odor control solutions for surgical incision care, the relevant considerations include the dressing’s antiseptic mechanism, its non-adherent design for atraumatic removal, available sizing and packing formats, and the regulatory and manufacturing standards underpinning the product. Xeroform Gauze Dressing from Roosin Medical is positioned to meet these criteria through its specific formulation of petrolatum, paraffin, and 3% Bismuth Tribromophenate, supported by sterile single-use manufacturing under recognized quality management frameworks.
https://www.roosin.com/
Roosin Medical Co., Ltd.